Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free FMS Stock Alerts

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

Fresenius Medical Care AG & Co. KGaA logo
$23.43 0.00 (0.00%)
As of 08/21/2026 03:58 PM Eastern
Compare

FMS vs. DGX, LH, GH, BTSG, and DVA

Should you buy Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? Fresenius Medical Care AG & Co. KGaA's main competitors and comparable companies include Quest Diagnostics (DGX), Labcorp (LH), Guardant Health (GH), BrightSpring Health Services (BTSG), and DaVita (DVA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Fresenius Medical Care AG & Co. KGaA compare to Quest Diagnostics?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Quest Diagnostics (NYSE:DGX) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

In the previous week, Quest Diagnostics had 28 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 30 mentions for Quest Diagnostics and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Quest Diagnostics' average media sentiment score of 1.37 beat Fresenius Medical Care AG & Co. KGaA's score of 1.27 indicating that Quest Diagnostics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Quest Diagnostics
27 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Quest Diagnostics has a net margin of 9.18% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Quest Diagnostics' return on equity of 16.01% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.83% 9.28% 4.16%
Quest Diagnostics 9.18%16.01%7.27%

Fresenius Medical Care AG & Co. KGaA presently has a consensus target price of $23.57, suggesting a potential upside of 0.58%. Quest Diagnostics has a consensus target price of $235.31, suggesting a potential downside of 3.70%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, equities analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Quest Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55
Quest Diagnostics
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.54

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.61 per share and has a dividend yield of 2.6%. Quest Diagnostics pays an annual dividend of $3.44 per share and has a dividend yield of 1.4%. Fresenius Medical Care AG & Co. KGaA pays out 31.6% of its earnings in the form of a dividend. Quest Diagnostics pays out 36.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Quest Diagnostics has increased its dividend for 14 consecutive years. Fresenius Medical Care AG & Co. KGaA is clearly the better dividend stock, given its higher yield and lower payout ratio.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Quest Diagnostics. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.57$1.11B$1.9312.14
Quest Diagnostics$11.04B2.44$992M$9.4225.94

Summary

Quest Diagnostics beats Fresenius Medical Care AG & Co. KGaA on 14 of the 20 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Labcorp?

Labcorp (NYSE:LH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

Labcorp pays an annual dividend of $2.88 per share and has a dividend yield of 0.9%. Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.61 per share and has a dividend yield of 2.6%. Labcorp pays out 23.8% of its earnings in the form of a dividend. Fresenius Medical Care AG & Co. KGaA pays out 31.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Labcorp has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Labcorp. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Labcorp$13.95B1.95$876.50M$12.0927.79
Fresenius Medical Care AG & Co. KGaA$22.20B0.57$1.11B$1.9312.14

In the previous week, Labcorp had 7 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 9 mentions for Labcorp and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.27 beat Labcorp's score of 0.66 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Labcorp
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Labcorp presently has a consensus target price of $330.00, suggesting a potential downside of 1.79%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.57, suggesting a potential upside of 0.58%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Labcorp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Labcorp
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55

Labcorp has a net margin of 6.99% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Labcorp's return on equity of 16.74% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Labcorp6.99% 16.74% 7.81%
Fresenius Medical Care AG & Co. KGaA 4.83%9.28%4.16%

95.9% of Labcorp shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Labcorp beats Fresenius Medical Care AG & Co. KGaA on 13 of the 18 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Guardant Health had 11 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 13 mentions for Guardant Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Guardant Health's average media sentiment score of 1.40 beat Fresenius Medical Care AG & Co. KGaA's score of 1.27 indicating that Guardant Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
12 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Guardant Health's net margin of -38.33%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-38.33% N/A -25.40%
Fresenius Medical Care AG & Co. KGaA 4.83%9.28%4.16%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$982.02M23.33-$416.28M-$3.49N/A
Fresenius Medical Care AG & Co. KGaA$22.20B0.57$1.11B$1.9312.14

Guardant Health has a beta of 1.6, suggesting that its stock price is 60% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market.

Guardant Health presently has a consensus price target of $183.78, indicating a potential upside of 7.67%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.57, indicating a potential upside of 0.58%. Given Guardant Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Guardant Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
23 Buy rating(s)
1 Strong Buy rating(s)
2.96
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55

Summary

Guardant Health beats Fresenius Medical Care AG & Co. KGaA on 10 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.55% 16.73% 5.24%
Fresenius Medical Care AG & Co. KGaA 4.83%9.28%4.16%

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

BrightSpring Health Services has a beta of 1.88, meaning that its share price is 88% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market.

In the previous week, BrightSpring Health Services had 6 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 8 mentions for BrightSpring Health Services and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.27 beat BrightSpring Health Services' score of 1.23 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BrightSpring Health Services presently has a consensus price target of $70.71, suggesting a potential upside of 20.11%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.57, suggesting a potential upside of 0.58%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, equities analysts clearly believe BrightSpring Health Services is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B0.90$190.67M$1.6635.46
Fresenius Medical Care AG & Co. KGaA$22.20B0.57$1.11B$1.9312.14

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 11 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to DaVita?

DaVita (NYSE:DVA) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

DaVita presently has a consensus price target of $221.75, indicating a potential upside of 27.29%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.57, indicating a potential upside of 0.58%. Given DaVita's stronger consensus rating and higher possible upside, equities research analysts plainly believe DaVita is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DaVita
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55

90.1% of DaVita shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 1.9% of DaVita shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

DaVita has a net margin of 6.05% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat DaVita's return on equity.

Company Net Margins Return on Equity Return on Assets
DaVita6.05% -217.63% 5.07%
Fresenius Medical Care AG & Co. KGaA 4.83%9.28%4.16%

DaVita has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than DaVita. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DaVita$13.64B0.81$746.80M$12.2214.26
Fresenius Medical Care AG & Co. KGaA$22.20B0.57$1.11B$1.9312.14

In the previous week, DaVita had 4 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 6 mentions for DaVita and 2 mentions for Fresenius Medical Care AG & Co. KGaA. DaVita's average media sentiment score of 1.76 beat Fresenius Medical Care AG & Co. KGaA's score of 1.27 indicating that DaVita is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DaVita
6 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

DaVita beats Fresenius Medical Care AG & Co. KGaA on 13 of the 16 factors compared between the two stocks.

Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically

Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FMS vs. The Competition

Export
MetricFresenius Medical Care AG & Co. KGaAHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$12.58B$9.83B$7.37B$24.30B
Dividend Yield2.59%2.55%2.53%3.70%
P/E Ratio12.1434.38272.6030.31
Price / Sales0.575.00624.3319.95
Price / Cash4.21125.1278.6232.49
Price / Book0.804.0513.056.77
Net Income$1.11B$311.06M$3.47B$1.07B
7 Day Performance-1.34%0.83%2.09%-0.65%
1 Month Performance-4.23%2.42%6.64%3.38%
1 Year Performance-8.39%15.69%25.02%14.90%

Fresenius Medical Care AG & Co. KGaA Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FMS
Fresenius Medical Care AG & Co. KGaA
3.1726 of 5 stars		$23.43
flat		$23.57
+0.6%		-8.4%$12.58B$22.20B12.141,488
DGX
Quest Diagnostics
4.2507 of 5 stars		$237.46
-0.4%		$235.31
-0.9%		+35.7%$26.31B$11.04B25.2157,000
LH
Labcorp
4.13 of 5 stars		$321.01
+0.6%		$330.00
+2.8%		+20.9%$25.88B$13.95B26.5571,000
GH
Guardant Health
2.8342 of 5 stars		$167.21
-0.8%		$183.78
+9.9%		+178.0%$22.61B$982.02MN/A2,506
BTSG
BrightSpring Health Services
4.9682 of 5 stars		$61.45
-1.6%		$70.71
+15.1%		+136.7%$12.35B$12.91B37.0223,500

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:FMS) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel